Mechanism of action<unk>  is a kinase inhibitor, more specifically a selective inhibitor of the enzyme mitogen-activated protein kinase kinase (MAPK kinase or MEK) subtypes 1 and 2. These enzymes are part of the MAPK/ERK pathway, which regulates cell proliferation (i.e., growth and division) and is overly active in many types of cancer.
Selumetinib
Binimetinib
Cobimetinib
Pralsetinib
Lestaurtinib
Axitinib
Mobocertinib
Gefitinib